Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer

Clinical trial NCT06283719 · RECRUITING

Trial details

NCT number: NCT06283719
Sponsor: Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Neuroendocrine Cancer

Start date: 2024-09-02
Primary completion: 2026-04-01
Enrollment: 265

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.